5 Diabetic Retinopathy Powerpoint Presentations
Epidemiology
* ( The World Health Organisation (1992) definition of blindness is vision less than 3/60 in the better eye with best available spectacle correction. )
* Diabetes is therefore one of the most serious challenges to health care world-wide. According to recent projections it will affect 239 million people by 2010- doubling in prevalence since 1994. Diabetes will affect 28 million in western Europe, 18.9 million in North America 138.2 million in Asia, 1.3 million in Australasia.
* Diabetes mellitus is the most common cause of blindness amongst individuals of working-age ( 20-65 years). The prevalence of blindness due to DR in Western Communities is estimated as between 1.6-1.9/ 100,000
Classification:
Non-proliferative diabetic retinopathy (NPDR)
Mild non-proliferative diabetic retinopathy
* Microaneurysms
* Dot and blot haemorrhages
* Hard ( intra-retinal ) exudates
Moderate-to-severe non-proliferative diabetic retinopathy
* The above lesions, usually with exacerbation, plus:
* Cotton-wool spots
* Venous beading and loops
* Intraretinal microvascular abnormalities ( IRMA )
Proliferative diabetic retinopathy
* Neovascularization of the retina, optic disc or iris
* Fibrous tissue adherent to vitreous face of retina
* Retinal detachment
* Vitreous haemorrhage
* Pre retinal haemorrhage
Maculopathy
* Clinically significant macular oedema (CSME )
* Ischaemic Maculopathy
Downloads
The Diabetic Retinopathy Clinical Research Network
Diabetic Retinopathy Screening Programme
Management of Diabetic Retinopathy
